Latest filing published 23 Jun 2026 for Atea Pharmaceuticals, Inc..
Insider track record
No signal scores available.
Jerome M. Adams: trading record in brief
Jerome M. Adams discloses dealings in Atea Pharmaceuticals, Inc. to SEC (Form 4). In total, 3 filings cover trades dated from 16 June 2024 to 18 June 2026.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 23 June 2026, the filings show an option exercise in Atea Pharmaceuticals, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Jerome M. Adams
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 29,600 sharesCommon StockSEC:0001193125-26-279720:0
- 29,600 shares0Common StockSEC:0000950170-25-089608:0
- 33,150 shares0Common StockSEC:0000950170-24-074984:0
3 of 3 declarations